• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imatron 1994 revenues rise by 34%

Article

Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31). Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits

Imatron, a manufacturer of ultra-high-speed CT systems, reported that sales jumped by 34% and the companyreturned to profitability in 1994 (ending Dec. 31).

Revenues last year totaled a record $33.5 million, comparedto $25.1 million in 1993. Profits were $2.3 million.

The financial good news is a continuation of positive trendsthat emerged in the second half of 1993, according to S. LewisMeyer, chief executive officer.

"The company moves into 1995 with a strong backlog anda high degree of optimism in our ability to continue growing,"he said.

Imatron is gearing up sales and marketing efforts in the PacificRim, Latin America and the Middle East. The launch of HeartScan,a subsidiary that will manage artery disease risk assessment centersequipped with Imatron high-speed CT scanners, is scheduled forthe first quarter of 1995, Meyer said.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.